Resources

Selected
  • 国电电力 2025年光伏毛利率
Type of publications
Regions
Diseases
273 results found
2025 ∙ Fu, X. Xia, Y. Zhou, W. Lu, Y.
Cost-effectiveness of human papillomavirus vaccination among girls aged 9-16 years in China: a meta-analysis
Western Pacific China Adolescents Human papillomavirus (HPV) Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Tamir, T. T. Tekeba, B. Techane, M. A. Alemu, T. G. Wubneh, C. A. Wassie, Y. A.
Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12-23 months in 41 low- and middle-income countries: A Meta-analysis of demographic and health survey reports between 2015 and 2025
Newborn Children Low and Middle Income Countries Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Cheuyem, F. Z. L. Amani, A. Achangwa, C. Ajong, B. N. Minkandi, C. A. Zeh, M. M. M. K. Ntsek, L. L. E. Essomba, J. P. Jiogue, R. C. Ndagijimana, O. Nchanji, N. E. Danwang, C.
COVID- 19 vaccine uptake and its determinants in Cameroon: a systematic review and meta-analysis (2021-2024)
Africa Cameroon All age groups Healthcare workers COVID-19 Coverage Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Karimi, R. Norozirad, M. Esmaeili, F. Mansourian, M. Marateb, H. R.
COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ McCosker, L. K. Dyer, B. Sudarmana, T. Seale, H. Ware, R. S.
COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis
All age groups COVID-19 Coverage Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Cheuyem, F. Z. L. Amani, A. Nkodo, I. C. A. Boukeng, L. B. K. Edzamba, M. F. Nouko, A. Guissana, E. O. Ngos, C. S. Achangwa, C. Mouangue, C.
COVID-19 vaccine acceptance and hesitancy in Cameroon: a systematic review and meta-analysis
Africa Cameroon All age groups Healthcare workers COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Pimenta, P. D. C. de Aquino Lima, T. C. Geraldine, V. G. S. Tourinho, F. S. do Nascimento, M. C. Novaes, R. D. Dias, L. M. R. P.
COVID-19 Vaccine Adverse Events by Country Income Level: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Mohammadi, S. Sisay, M. M. Saraswati, P. W. Osman, A. K. Zuithoff, N. P. A. Weibel, D. Sturkenboom, M. Ahmadizar, F.
COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Al hashimi, F. Shuaib, S. E. Bragazzi, N. L. Chen, S. Wu, J.
COVID-19 Vaccine Timing and Co-Administration with Influenza Vaccines in Canada: A Systematic Review with Comparative Insights from G7 Countries
Americas Canada All age groups Healthcare workers COVID-19 Influenza Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Georgiadis, N. Katsimpris, A. Tzanakaki, G. Tsiodras, S. Beloukas, A. Vassilakou, T. Sergentanis, T. N.
Cross-protection of meningococcal B vaccines against gonorrhea: A systematic review and Meta-analysis
All age groups Meningococcal disease Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...